Who will benefit from ACE inhibition?

Heart Podcast
23/04/2013 11 min Episodio 2
Who will benefit from ACE inhibition?

Listen "Who will benefit from ACE inhibition?"

Descargar episodio Ver en sitio original

Episode Synopsis

Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.
See also:
Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP http://bit.ly/11hAfKc

More episodes of the podcast Heart Podcast

Can we predict coronary artery disease on CT using machine learning - insights from the SCOT-HEART trial 30/12/2025
Therapies for ventricular tachycardia 16/12/2025
Evolution of coronary stents: innovations, antithrombotic strategies and future directions 02/12/2025
Planetary health meets cardiology: A call to action 18/11/2025
Predicting cardiovascular events from routine mammograms using machine learning 04/11/2025
Predicting 1-year futility of TAVI procedures using machine learning 21/10/2025
Top 10 statistical errors in submitted papers...and how to avoid them 07/10/2025
Wearable device technology and the future of patient assessment 23/09/2025
Change in body weight, cardiovascular disease and mortality 09/09/2025
Strategies to increase female participation in cardiovascular clinical trials 26/08/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA